Enforced η1-Fluorenyl and Indenyl Coordination to Zirconium
Organometallics, Vol. 26, No. 27, 2007 6803
crystallography were obtained from a toluene/pentane solution at
mL)/pentane (0.5 mL) mixture at -25 °C. 31P{1H} NMR (202.5
MHz, CD2Cl2, 287 K): δppm 12.6. 1H{31P} NMR (500 MHz,
CD2Cl2, 287 K): δppm 7.70–7.59 (m, 2H, H17), 7.40–7.36 (m, 4H,
H16), 7.32–7.12 (m, 4H, H15), 7.23 (m, 1H, H13), 7.17 (m, 2H, H12),
room temperature. 31P{1H} NMR (121.4 MHz, C6D6): δppm 21.3
1
3
(s). H NMR (300.1 MHz, C6D6): δppm 8.04 (d, JH,H ) 7.5 Hz,
2H, H6,6′), 7.28–7.08 (m, 10H, H4,4′,6,6′,9,9′,13), 7.08–7.00 (m, 11H,
3
3
H
3,3′,10,11,19), 6.95–6.85 (m, 5H, H15,20), 6.80–6.70 (m, 4H, H14), 6.58
7.12 (pseudo t, 6H, JH,H ) 7.5 Hz, H21), 6.87 (t, 3H, JH,H ) 7.0
3
(d, JH,H ) 8.1 Hz, 6H, H18), 2.17 ppm (s, 6H, H16). 13C{1H}-
3
3
Hz, H22), 6.77 (d, 6H, JH,H ) 7.5 Hz, H20), 3.30 (sept, 2H, JH,H
) 6.6 Hz, -CH-(CH3)2), 2.40 (very br s, 3H, H18), 1.80 (very br s,
3H, H18′), 0.94 (br s, 6H, -CH(CH3)2), 0.79 (br s, 6H, -CH(CH3)2).
13C{1H} NMR (125.3 MHz, CD2Cl2, 287 K): δppm 150.5 (C19),
145.4 (d, 3JC,P ) 5.5 Hz, C11), 141.3 (d, 2JC,P ) 6.9 Hz, C10), 133.6
NMR (75.5 MHz, C6D6): δppm 146 (C17), 141.3 (d, 2JC,P ) 6.5 Hz,
3
2
C2,2′), 137.0 (d, JC,P ) 10.3 Hz, C7,7′), 132.8 (d, JC,P ) 10.3 Hz,
2
C13), 132.4 (C15), 129.2 (C3,3′), 129.1 (d, JC,P ) 81.0 Hz, C12),
2
128.8 (d, JC,P ) 11.8 Hz, C14), 128.2 (C19), 127.9 (C18), 126.3
2
4
(C10), 126.1 (C4,4′), 123.4 (C5,5′), 123.2 (C9,9′), 122.3 (C20), 120.8
(br d, JC,P ) 9.0 Hz, C15), 133.3 (d, JC,P ) 2.7 Hz, C17),
2
3
(C6,6′), 120.1 (C11), 79.7 (C16), 56.0 ppm (d, JC,P ) 96.6 Hz, C1),
C8 not observed. Mp: 146 °C dec.
128.9–129.1 (d, JC,P ) 13.1 Hz, C16), 127.9 (C21), 126.4 (C20),
125.4 (C13), 124.9 (C12), 120.9 (C22), 78.5 (C18), 73.5 (very br, C1),
28.6 (CH(CH3)2), 23.9–24.5 (CH(CH3)2). Mp: 129–130 °C dec.
Synthesis of ZrBn3(Ph2IndPdNMes) (7c). A solution of 4c
(200 mg, 0.46 mmol) and ZrBn4 (230 mg, 0.50 mmol) in toluene
(1.5 mL) was stirred at room temperature in the absence of light
for 4 h. The reaction can also be performed in diethyl ether (8
mL). Although a slightly longer reaction time (14 h) was required,
probably due to the poor solubility of 4c in this solvent, the resulting
complex 7c directly precipitated from the reaction mixture, which
facilitated the workup. The yellow precipitate was washed with
toluene (0.5 mL), and 7c was obtained as a yellow powder (0.26
g, 70%). Orange crystals of 7c suitable for X-ray crystallography
were obtained from a dichloromethane (0.5 mL)/pentane (1 mL)
mixture at -10 °C. 31P{1H} NMR (202.5 MHz, CD2Cl2): δppm 13.4.
1H{31P} NMR (500 MHz, CD2Cl2): δppm 7.70 (d, 1H, 3JH,H ) 8.0
Hz, H6), 7.78 and 7.67 (br s, 1H each, H17), 7.57 and 7.34 (br s,
Synthesis of Complex 6c. Reaction Performed in an NMR
Tube. A solution of 2c (36 mg, 0.08 mmol) and ZrBn4 (58 mg,
0.13 mmol, 1.7 equiv) in toluene-d8 (0.75 mL) was heated at 90
°C in the absence of light for 5 days. Complete consumption of
the ligand was observed. 31P{1H} NMR (81 MHz, toluene-d8): δppm
1
3
15.1 (s). H NMR (400 MHz, toluene-d8): δppm 7.98 (d, JH,H
)
7.8 Hz, 2H, H6,6′), 7.52 (m, 4H, H13), 7.18 (m, 2H, H5,5′), 7.03 (m,
2H, H15), 6.96 (m, 2H, H19), 6.94 (m, 2H, H4,4′), 6.90 (m, 5H, H10,14),
6.86 (m, H20), 6.69 (m, 1H, H10′), 6.68 (m, 2H, H3,3′), 5.94 (d, 3JH,H
) 8.0, 4H, H18), 2.30 (s, 3H, p-CH3), 2.08 (s, 3H, o-CH3), 1.80 (s,
2H, CH2Ar), 1.47 and 1.49 (2 s, 2H each, H16). 13C NMR (100
2
MHz, toluene-d8): δppm 145.9 (d, JC,P ) 6.5 Hz, C8), 144.8 (d,
3JC,P ) 15.6 Hz, C9′ Ar ipso-bridge), 142.3 (C17), 141.8 (d, 2JC,P
)
)
3
4
7.8 Hz, C2,2′), 136.8 (d, JC,P ) 10.0 Hz, C7,7′), 132.8 (d, JC,P
2
4
8.0 Hz, C11), 132.5 (d, JC,P ) 9.9 Hz, C13), 132.0 (d, JC,P ) 2.8
2H each, H16) 7.34 and 6.98 (br s, 2H each, H15), 7.27 (m, 1H,
Hz, C15), 130.5 (C19), 128.6 (C14), 128.3 (C10), 127.5 (C10′), 127.0
3
4
3
H5), 7.08 (m, 6H, H21), 7.02 (m, 1H, H4), 6.97 (dd, 1H, JH,H
)
)
(C18,18′), 125.3 (d, JC,P ) 1.2 Hz, C4,4′), 125.0 (d, JC,P ) 1.7 Hz,
4
3
3
C9), 122.8 (C20), 122.5 (C5,5′), 121.0 (d, 3JC,P ) 1.3 Hz, C3,3′), 120.5
4.2 Hz, JH,P ) 3.1 Hz, H8), 6.94 (d, 1H, JH,H ) 4.2 Hz, JH,P
3
1
2.6 Hz, H9), 6.87 (m, 5H, H22 and H12), 6.52 (d, 6H, JH,H ) 7.5
(C6,6′), 74.5 (C16), 68.7 (CH2 Ar), 57.6 (d, JC,P ) 100.6 Hz, C1),
3
23.2 (o-CH3), 20.8 (p-CH3).
Hz, H20), 6.33 (d, 1H, JH,H ) 8.5 Hz, H3), 2.32 (s, 3H, p-CH3),
3
2.19 (br d, 3H, JH,H ) 10.0 Hz, H18), 1.95 (m, 9H, overlapped
Synthesis of ZrBn3(Ph2IndPdNPh) (7a). Reaction
performed in an NMR Tube. Compound 4a (39 mg, 0.1 mmol)
and ZrBn4 (46 mg, 0.1 mmol, 1.0 equiv) were dissolved in
dichloromethane-d2 (0.6 mL) at room temperature and manually
shaken for a few minutes. Complete consumption of the ligand was
observed. Pale yellow-orange crystals of 7a suitable for X-ray
crystallography were obtained from a toluene (1 mL)/pentane (0.4
mL) mixture at 0 °C. 31P{1H} NMR (202.5 MHz, CD2Cl2, 250
o-CH3 and H18′). 13C{1H} NMR (125.3 MHz, CD2Cl2): δppm 148.1
2
3
(C19), 141.5 (d, JC,P ) 6.7 Hz, C10), 137.5 (d, JC,P ) 12.3 Hz,
C7), 134.9 (d, 3JC,P ) 4.9 Hz, C11), 134.5 (d, 2JC,P ) 13.0 Hz, C2),
134.3 (C13), 134.0 and 133.5 (br s, C17), 132.7 and 132.0 (br d,
2JC,P ≈ 7.0 Hz, C15), 129.0 and 128.5 (br d, JC,P ≈ 10.0 Hz C16),
3
3
128.2 (C21), 127.0 (C20), 124.3 (C4), 124.0 (d, JC,P ) 11.9 Hz,
2
C8), 123.4 and 123.3 (C4 or C5), 121.5 (C22), 121.0 (d, JC,P
)
1
1
K): δppm 17.6. H{31P} NMR (500 MHz, CD2Cl2, 250 K): δppm
11.0 Hz, C9), 120.9 (C4), 79.1 (C18), 71.3 (d, JC,P ) 118.7 Hz,
C1), 21.4 (o-CH3), 20.4 (p-CH3).
7.80 (d, 1H, 3JH,H ) 7.9 Hz, H6), 7.67 (m, 2H, H17), 7.44 (m, 4H,
H16), 7.40 (overlapped, 1H, H5), 7.39–7.34 (m, 4H, H15), 7.28
(overlapped, 1H, H6), 7.22 (m, 2H, H12), 7.15 (pseudo t, 6H, 3JH,H
) 8.0 Hz, H21), 7.02 (d, 1H, 3JH,H ) 4.6 Hz, H8), 6.98 (t, 3H, 3JH,H
Synthesis of Complex 8c. A solution of 7c (100 mg, 0.12 mmol)
in toluene (2.5 mL) was heated at 80 °C in the absence of light for
5 h and evaporated to dryness. The brown residue was dissolved
in dichloromethane-d2 (0.5 mL) and transferred to an NMR tube.
31P{1H} NMR (202.5 MHz, CD2Cl2,): δppm 7.4. 1H{31P} NMR
3
) 7.0 Hz, H22), 6.90 (d, 1H, JH,H ) 7.9 Hz, H3), 6.73 (d, 2H,
3
3JH,H ) 7.6 Hz, H11), 6.60 (t, 1H, JH,H ) 7.9 Hz, H13), 6.57 (d,
(500.3 MHz, CD2Cl2): δppm 7.98 (dd, 2H, 3JH,H ) 7.2 Hz, 3JH,P
)
3
3
1H, JH,H ) 4.6 Hz, H9), 6.48 (d, 6H, JH,H ) 8.0 Hz, H20), 2.02
(d, 3H, 2JH,H ) 10.5 Hz, H18), 1.89 (d, 3H, 2JH,H ) 10.5 Hz, H18′).
13C{1H} NMR (125.3 MHz, CD2Cl2, 250 K): δppm 146.3 (C19),
146.0 (d, 2JC,P ) 5.0 Hz, C10), 140.7 (d, 3JC,P ) 11.3 Hz, C7), 134.6
12.9 Hz, H15), 7.85 (t, 1H, 3JH,H ) 7.5 Hz, H17), 7.71 and 7.65 (dt,
3
3
3
2H, JH,H ≈ 8.0 Hz, JH,P ≈ 3.0 Hz, H16), 7.57 (br d, 1H, JH,H
)
8.5 Hz, H6), 7.55–7.49 (m, 3H, H15 17), 7.35 (m, 1H, H5),
and
2
4
7.12–7.00 (m, 4H, H21), 7.03 (overlapped, 1H, H4), 6.90–6.80 (m,
(d, JC,P ) 10.1 Hz, C2), 133.3 (d, JC,P ) 2.5 Hz, C17), 132.8 (d,
3
3
2JC,P ) 11.0 Hz, C15), 129.7 (d, JC,P ) 11.3 Hz, C9), 129.4 (d,
2
2H, H22), 6.93 (d, 1H, JH,H ) 3.8 Hz, H8), 6.74 (d, 2H, JH,H
)
3
3JC,P ) 10,5 Hz, C16), 129.3 (C12), 128.9 (C21), 128.2 (d, JC,P
)
1
7.5 Hz, H20), 6.73 (s, 1H, H12), 6.67 (d, 1H, JH,H ) 8.0 Hz, H20),
3
3
6.54 (d, 1H, JH,H ) 7.5 Hz, H20), 6.41 (s, 1H, H12′), 6.27 (d, 1H,
87.0 Hz, C14), 127.2 (C20), 125.8 (d, JC,P ) 10.0 Hz, C11), 124.1
(C4), 124.0 (C13), 123.5 (C5), 123.2 (C6), 122.1 (C22), 119.7 (d,
3JC,P ) 12.5 Hz, C8), 118.4 (C3), 78.4 (C18), 67.8 (d, 1JC,P ) 111.4
Hz, C1).
3JH,H ) 3.8 Hz, H9), 6.11 (d, 1H, 3JH,H ) 8.5 Hz, H3), 2.53 (d, 1H,
3JH,H ) 13.8 Hz, Zr-CH2-o-Mes), 2.43 (d, 1H, JH,H ) 13.8 Hz,
3
Zr-CH2-o-Mes), 2.27 (s, 3H, o-CH3), 2.07 (d, 1H, 3JH,H ) 9.9 Hz,
H18), 1.99 (d, 1H, 3JH,H ) 9.9 Hz, H18′), 1.60 (s, 3H, p-CH3), 1.19
Synthesis of ZrBn3(Ph2IndPdN(i-Pr2)C6H3) (7b). A solution
of 4b (144 mg, 0.30 mmol) and ZrBn4 (194 mg, 0.43 mmol) in
toluene (1.5 mL) was stirred at room temperature in the absence
of light for 10 h. The solution orange was filtered and placed at 0
°C for 15 h. The yellow precipitate formed was filtered and washed
with cold (-20 °C) toluene (2 mL). Compound 7b was obtained
as a pale yellow powder (0.16 g, 64%). Yellow crystals of 7b
suitable for X-ray crystallography were obtained from a THF (1
3
3
(d, 1H, JH,H ) 9.7 Hz, H18), –0.06 (d, 1H, JH,H ) 9.7 Hz, H18′).
13C{1H} NMR (125.3 MHz, CD2Cl2): δppm 150.6 (C19), 147.6 (d,
2JC,P ) 19.7 Hz, C10), 143.1 (C19′), 141.5 (d, 2JC,P ) 6.7 Hz, C10),
137.5 (d, 3JC,P ) 12.3 Hz, C7), 134.9 (d, 3JC,P ) 4.9 Hz, C11), 134.5
(d, 2JC,P ) 13.0 Hz, C2), 132.9 and 133.7 (d, 4JC,P ) 3.0 Hz, C17),
131.3 and 132.8 (d, 2JC,P ∼ 10–11 Hz, C15), 129.6 and 129.7 (br d,
3JC,P ≈ 12.6 Hz, C16), 128.3 and 128.1 (C20), 128.2 (C22), 127.9